Deepika Sivakumar, PharmD

Piloting new emergency department-based vaccination campaigns and fine-tuning existing programs may reduce morbidity and mortality associated with vaccine-preventable diseases.

Cefiderocol and IV fosfomycin are exciting new options, and further clinical outcomes data will help define their roles.